Advertisement

Rejuvenate your look with Texas cosmetic surgery and Ohio cosmetic surgery.

Home
UCLA Launches New Institute of Urologic Oncology
Written by Kim Irwin   
Friday, 06 March 2009
Los Angeles, California - UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers.
 
Read more...
 
Developing Orphan Products: FDA and Rare Disease Day
Written by IV Post   
Wednesday, 04 March 2009

Washington, DC - Organizations around the world are observing February 28, 2009, as the 2nd annual World Rare Disease Day - an important time for bringing attention to the needs of people with rare diseases.

Read more...
 
Guide to Safe Use of Pain Medicine
Written by FDA   
Wednesday, 04 March 2009

Washington, DC - If you've ever been treated for severe pain from surgery, an injury, or an illness, you know just how vital pain relief medications can be. Pain relief treatments come in many forms and potencies, are available by prescription or over-the-counter (OTC), and treat all sorts of physical pain  including that brought on by chronic conditions, sudden trauma, and cancer.

 

Read more...
 
Reducing Radiation from Medical X-rays
Written by FDA   
Wednesday, 04 March 2009

Washington, DC - One of medicine's most remarkable achievements is the use of X-rays to see inside the body without having a surgeon wield a scalpel.

Read more...
 
Improper Use of Skin Numbing Products Can Be Deadly
Written by FDA   
Wednesday, 04 March 2009

Washington, DC - In January 2009, the Food and Drug Administration (FDA) issued a public health advisory about the improper use of skin numbing products. Also known as topical anesthetics, these products have been used to lessen pain in certain procedures such as skin treatments and laser hair removal.

Read more...
 
FDA Takes Action Against KV Pharmaceutical Company
Written by San Diego Newscape   
Tuesday, 03 March 2009

The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs. The injunction against KV and the other defendants, once entered by the court, will prevent them from manufacturing and shipping drugs until the firm obtains FDA approval.

Read more...
 
Governor Schwarzenegger on President Obama Selecting Kathleen Sebelius for Health and Human Services
Written by IV Post   
Monday, 02 March 2009

Sacramento, California - California Governor Arnold Schwarzenegger today issued a statement following President Obama’s selection of Kansas Governor Kathleen Sebelius for Secretary of Health and Human Services:

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 109 - 120 of 614

Login Form






Lost Password?
No account yet? Register

Syndicate

feed image
feed image